SGN has swapped an IT managed service from Fujitsu with a five-year agreement with CGI as part of its plans to introduce features such as artificial intelligence (AI) to speed up service desk response ...
Culver City’s Social Gaming Network, a mobile game developer, on Thursday announced a $130 million investment from South Korean game publisher Netmarble Games. The investment makes Netmarble the ...
Mobile gaming company SGN announced today that it has a new name, Jam City. This isn’t the first time the company has rebranded — it was called MindJolt before acquiring SGN and then taking on the ...
Signing Day Sports, Inc. operates a sports recruitment platform in the United States. The company offers Signing Day Sports, a sports recruitment platform that helps athletes get discovered and ...
SGN, a fast-growing developer of freemium mobile games like “Cookie Jam,” has banked $130 million from Netmarble Games, the top mobile-games publisher in South Korea. The deal makes Netmarble the ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...
“SGN leads the way in our industry’s Customer Satisfaction levels”, 2019 CIO 100 leader Andrew Quail told CIO UK. “But we’re always looking at ways to improve our customers’ experience as well as our ...
Ofgem has given gas distributor SGN approval to move onto the next stage of a project to trial hydrogen gas through a decommissioned pipeline in Scotland. Launched in April 2022, SGN’s £30m LTS ...
Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib Clinical Trial in Combination with Rituxan for Non-Hodgkin Lymphoma BOTHELL, Wash. -- Jan. 7, 2008--Seattle Genetics, ...
Gas distribution company SGN faces a six-figure compensation bill after 8,000 homes in the Falkirk area were left without gas following an outage. As of 14:00 on Wednesday, SGN had visited every ...
CHICAGO--(BUSINESS WIRE)-- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the presentation of interim data from an ongoing phase I clinical trial of SGN-75 in renal cell carcinoma (RCC) and non ...
SGN is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of SGN shares has decreased $0.08 since the market last closed. This is a 7.35% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback